Abstract | AIM: Describe the rationale for and design of Diabetes Remote Intervention to improVe use of Evidence-based medications (DRIVE), a remote medication management program designed to initiate and titrate guideline-directed medical therapy (GDMT) in patients with type 2 diabetes (T2D) at elevated cardiovascular (CV) and/or kidney risk by leveraging non-physician providers. METHODS: An electronic health record based algorithm is used to identify patients with T2D and either established atherosclerotic CV disease (ASCVD), high risk for ASCVD, chronic kidney disease, and/or heart failure within our health system. Patients are invited to participate and randomly assigned to either simultaneous education and medication management, or a period of education prior to medication management. Patient navigators (trained, non-licensed staff) are the primary points of contact while a pharmacist or nurse practitioner reviews and authorizes each medication initiation and titration under an institution-approved collaborative drug therapy management protocol with supervision from a cardiologist and/or endocrinologist. Patient engagement is managed through software to support communication, automation, workflow, and standardization. CONCLUSION: We are testing a remote, navigator-driven, pharmacist-led, and physician-overseen management strategy to optimize GDMT for T2D as a population-level strategy to close the gap between guidelines and clinical practice for patients with T2D at elevated CV and/or kidney risk.
|
Authors | Alexander J Blood, Lee-Shing Chang, Caitlin Colling, Gretchen Stern, Daniel Gabovitch, Guinevere Feldman, Asma Adan, Fanta Waterman, Emily Durden, Carol Hamersky, Joshua Noone, Samuel J Aronson, Paul Liberatore, Thomas A Gaziano, Lina S Matta, Jorge Plutzky, Christopher P Cannon, Deborah J Wexler, Benjamin M Scirica |
Journal | Primary care diabetes
(Prim Care Diabetes)
Vol. 18
Issue 2
Pg. 202-209
(04 2024)
ISSN: 1878-0210 [Electronic] England |
PMID | 38302335
(Publication Type: Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. |
Topics |
- Humans
- Diabetes Mellitus, Type 2
(diagnosis, drug therapy)
- Pharmacists
- Kidney
- Renal Insufficiency, Chronic
(diagnosis)
- Disease Management
- Cardiovascular Diseases
(diagnosis, epidemiology, etiology)
|